Equity - Disclosure of development of outstanding shares (Details) - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Equity [abstract] | ||
| Number of shares outstanding, beginning balance (in shares) | 162,397,202 | 138,787,820 |
| Share-based compensation exercises (in shares) | 1,684,889 | 609,382 |
| Capital Increase (in shares) | 9,333,332 | 23,000,000 |
| Number of shares outstanding, ending balance (in shares) | 173,415,423 | 162,397,202 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of share options exercised in a share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|